| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MOT.0B013E32835D4DAF |
| P698 | PubMed publication ID | 23283250 |
| P2093 | author name string | Mark Haas | |
| P433 | issue | 3 | |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 319-326 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Current opinion in organ transplantation | Q26842426 |
| P1476 | title | Pathology of C4d-negative antibody-mediated rejection in renal allografts | |
| P478 | volume | 18 |
| Q38211716 | A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection |
| Q61945632 | Analysis of Specificity of Anti–Human Leukocyte Antigen Antibodies in Kidney Recipients in Reference to Clinical Outcome |
| Q52401610 | Antibody-mediated rejection: New approaches in prevention and management. |
| Q38334458 | B-cell biomarkers in transplantation--from genes to therapy. |
| Q40417954 | C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study |
| Q38430795 | C4d immunoreactivity of intraoperative zero-hour biopsy in renal allograft |
| Q35922715 | Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection |
| Q35235186 | Clinical impact of H-Y alloimmunity |
| Q92112040 | Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection |
| Q38609238 | Complement inhibition as potential new therapy for antibody-mediated rejection. |
| Q48258667 | De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation |
| Q34106643 | Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival |
| Q40266578 | HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion |
| Q52373711 | HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. |
| Q27006030 | Late and chronic antibody-mediated rejection: main barrier to long term graft survival |
| Q39138227 | Molecular diagnostics in renal allograft biopsy interpretation: potential and pitfalls |
| Q40882063 | The impact of C4d-negative acute antibody-mediated rejection on short-term prognosis among kidney transplant recipients |
| Q26862195 | The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection |
| Q38247690 | The significance of histological diagnosis in renal allograft biopsies in 2014. |
| Q92899718 | The therapeutic challenge of late antibody-mediated kidney allograft rejection |
| Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
| Q50743724 | Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection. |
Search more.